An experimental study to investigate the effects of venlafaxine and escitalopram on anticonvulsant activity of conventional antiepileptic drugs in mice


  • Santosh Kumar Singh Department of Pharmacology, Armed Forces Medical College, Pune, Maharashtra, India
  • Anamika Singh Department of Oral Medicine and Radiology, Dr. D.Y. Patil Dental College and Hospital Pimpri, Pune, Maharashtra, India



Antiepileptics, Antidepressants, Maximal electroshock, Seizures, Seizure threshold


Background: Depression is a common psychiatric comorbidity in patients with epilepsy which remains often untreated, due to concern of antidepressant induced seizures. The safety status of selective serotonin reuptake inhibitors (SSRIs) in epileptics is controversial.

Methods: Phase I acute effect of venlafaxine and escitalopram on the seizure threshold was studied. Phase II, the acute effects of test ADDs on the effective dose of AEDs viz valproate, phenobarbitone and phenytoin were studied in maximal electroshock (MES). Phase III- same study design as in phase II except that AEDs and ADDs were administered daily for 28 days.

Results: Venlafaxine raised the electroconvulsive threshold in a dose dependant manner in phase I, however it was significant at a dose of 25mg/kg. In phase II, a significant reduction in ED50 of valproate was observed when it was co-administered with venlafaxine at dose of 12.5 and 25mg/kg, whereas ED50 of phenobarbitone was significantly reduced at a dose of 25mg/kg. Chronic administration of venlafaxine at 12.5mg/kg daily reduced ED50 of valproate. At 25mg/kg daily ED50 of all the three studied AEDs was reduced, Escitalopram 8mg/kg significantly raised the electroconvulsive threshold value in phase 1, Escitalopram administered in the dose of 8mg/kg reduced the ed50 value of valproate. Escitalopram given in dose of 4 and 8mg/kg reduced the ED50 value of valproate.

Conclusions: From this finding, it may be concluded that venlafaxine and escitalopram administered either alone or in combination with AEDs acutely or chronically, exhibit anticonvulsant action.


Ebert U. Basic mechanisms of psychotropic drugs. Epilepsia. 2002;43(s2):2-7.

Mula M, Schmitz B. Review: Depression in epilepsy: mechanisms and therapeutic approach. Therapeutic advances in neurological disorders. 2009;2(5):337-44.

Cardamone L, Salzberg M, O'Brien T, Jones N. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? British journal of pharmacology. 2013;168(7):1531-54.

Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochemical pharmacology. 1996;52(9):1323-9.

Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia. 1999;40(10):S48-56.

Borowicz KK, Stêpieñ K, Czuczwar Sa J. Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacological reports. 2006;58(1):83.

Borowicz KK, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar SJ. Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Eur J of Pha. 2007;567(1):77-82.

Raju S, Noor A, Gurthu S, Giriyappanavar C, Acharya S, Low H, et al. Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration. Pharmacological research. 1999;39(6):451-4.

Borowicz KK, Banach M, Zarczuk R, Lukasik D, Luszczki JJ, Czuczwar SJ. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Psychopharmacology. 2007;195(2):167-74.

Kumar M. A study on effect of trazadone, amoxapine and venlafaxine on MES (maximal electroshock) induced seizures in albino rats.

Borowicz KK, Gołyska D, Luszczki JJ, Czuczwar SJ. Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model. Eur J of Pha. 2011;670(1):114-20.

Aricioglu F, Salanturoglu G, Buldanlioglu U, Ozyalcin S. Effect of venlafaxine on maximal electroshock induced seizures in mice. Annals of General Psychiatry. 2006 Feb 1;5(S1):S103.

Santos Junior J, Do Monte F, Russi M, Agustine P, Lanziotti V. Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats. Brazilian journal of medical and biological research. 2002;35(4):469-72.

Favale E, Audenino D, Cocito L, Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure: The J of the British Epilepsy Association. 2003;12(5):316-8.

Bahremand A, Payandemehr B, Rahimian R, Ziai P, Pourmand N, Loloee S, et al. The role of 5-HT 3 receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice. Epilepsy and Behavior. 2011;21(2):122-7.

Care V. CPCSEA Guidelines for laboratory animal facility. Indian Journal of Pharmacology. 2003;35:257-74.

Randhawa MA. Calculation of LD50 values from the method of Miller and Tainter, 1944. Journal of Ayub Medical College, Abbottabad: JAMC. 2009;21(3):184-5.

Gupta D, Bhardwaj S. Study of Acute, Subacute and Chronic Toxicity Test. Int J Cur Biomed Phar Res. 2012;2(2):290-89.

Turner R, Quantal responses. Calculation of ED50. In Screening Methods in Pharmacology, Academic Press, New York; 1965:61-63.

Castel-Branco MM, Alves GL, Figueiredo IV, Falcao AC, Caramona MM. The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Methods and findings in experimental and clinical pharmacology. 2009;31(2):101-6.

Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy and behavior. 2003;4(3):S14-24.

Jobe PC. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Clinical EEG and neuroscience: Official Journal of the EEG and Clinical Neuroscience Society. 2004;35(1):53-68.

Clinckers R, Zgavc T, Vermoesen K, Meurs A, Michotte Y, Smolders I. Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures. Journal of Neurochemistry. 2010;115(6):1595-607.

Vermoesen K, Massie A, Smolders I, Clinckers R. The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia. 2012;53(5):870-8.

Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature medicine. 2010;16(4):413-9.

Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proceedings of the National Academy of Sciences. 2000;97(21):11534-9.




How to Cite

Singh, S. K., & Singh, A. (2017). An experimental study to investigate the effects of venlafaxine and escitalopram on anticonvulsant activity of conventional antiepileptic drugs in mice. International Journal of Basic & Clinical Pharmacology, 6(7), 1701–1707.



Original Research Articles